Form 144: DBX executive reports 10b5-1 stock sales
DBX insider reported planned dispositions of Common Stock under a Rule 10b5-1 plan.
Rhea-AI Filing Summary
DBX insider reported planned dispositions of Common Stock under a Rule 10b5-1 plan. The filing lists multiple 10b5-1 sales by Sarah Schubach on 04/15/2026, 04/30/2026, 05/19/2026, 06/01/2026, and 06/15/2026, with the reported amounts 32530.85, 42367.55, 36750.84, 36096.30, and 35131.40 respectively.
Positive
- None.
Negative
- None.
Insights
Multiple Rule 10b5-1 automated sales by an executive are recorded across spring 2026.
These entries list dates and numeric amounts tied to Common Stock dispositions executed under a 10b5-1 plan for Sarah Schubach. The filing names the broker as Morgan Stanley Smith Barney LLC and identifies the security as Common stock.
These transactions are procedural disclosures; cash‑flow treatment and unit labels are not shown in the excerpt. Subsequent public filings may provide further detail on share counts or dollar values.
Key Figures
Key Terms
10b5-1 regulatory
Restricted Stock Units financial
Form 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the DBX Form 144 disclose about insider sales?
Were the sales reported as part of a 10b5-1 plan for DBX insiders?
Which broker handled the reported DBX transactions?
Do the filings show any securities other than Common Stock?
AI-generated analysis. How Rhea-AI works. Not financial advice.